News

ECRIN’s Independent Certification Board certified two clinical trial units (CTUs) as high-quality data centres in July 2016. The certified institutions are the Clinical Pharmacology and Therapeutic…...

ECRIN signed a memorandum of understanding (MoU) in July 2016 with the Foundation for Biomedical Research and Innovation (FBRI) in Japan and the Oswaldo Cruz Foundation (Fundacao Oswaldo Cruz,…...

ECRIN's Director General, Jacques Demotes, provides a brief report on this year's celebration of International Clinical Trials Day (ICTD). The ICTD 2016 conference on “Clinical trials in the era of…...

The FAIR-PARK II trial (Conservative Iron Chelation as a Disease-Modifying Strategy in Parkinson's Disease, PD) has held site initiation visits at all participating sites in France (sponsor country)…...

ECRIN has contributed to a new scientific publication entitled "Evidence-based clinical practice: Overview of threats to the validity of evidence and how to minimise them". Published in European…...

As part of the CORBEL project, ECRIN has prepared a short survey for users of research infrastructures (RIs) in Europe. Funded by the European Union Horizon 2020 research and innovation programme,…...

The meeting aims to increase awareness of ECRIN and its Czech national scientific partner – the Czech Clinical Research Infrastructure Network (CZECRIN) – and to address issues related to…...

ECRIN has been listed as an “ESFRI Landmark” on the European Strategy Forum on Research Infrastructures (ESFRI) Roadmap 2016, launched on March 10th, 2016 in Amsterdam. ESFRI identifies Research…...